The US Preventive Services Task Force (USPSTF) issued a draft recommendation regarding breast cancer screening in women aged 40 years old to 74 years old.
Researchers aimed to longitudinally examine both the variability of musculoskeletal pain among individuals with breast cancer and any potential predictors for pain during the first 18 months of aromatase...
The researchers evaluated the impact of antirheumatic treatment in women who are pregnant with psoriatic arthritis and how such treatment affects pregnancy outcomes.
Women with breast cancer who are receiving dose-dense paclitaxel are more likely to experience paclitaxel-induced peripheral neuropathy (PIPN) when compared with women who receive the treatment weekly,...
As neurocognitive decline occurs in the majority of patients with breast cancer, researchers conducted a blind randomized trial to determine if aerobic exercise was an effective intervention for reducing...
Researchers evaluated the response rate of gemcitabine in patients with platinum-resistant ovarian cancer given at a low dosage. Their research was presented at the Hematology/Oncology Pharmacy...
The results of a recent study presented at the 2023 Hematology/Oncology Pharmacy Association annual conference suggest health care providers should be vigilant about the overutilization of potentially...
This COVID-19 roundup includes research on an alternative therapy to nirmatrelvir-ritonavir, a vaccine regimen that protects pregnant women and infants against certain variants, pegylated interferon lambda...
In a recent clinical trial, researchers determined that mothers who took vitamin D supplements during pregnancy reduced the risk of atopic eczema in the baby’s first year.
A team of researchers examined the association between combined hormonal contraceptive use in women and its protection against musculoskeletal conditions and injuries.
